Lactic Acid Bacteria and Lactic Acid for Skin Health and Melanogenesis Inhibition

Author(s): Huey-Chun Huang, I. Jung Lee, Chen Huang, Tsong-Min Chang*

Journal Name: Current Pharmaceutical Biotechnology

Volume 21 , Issue 7 , 2020

DOI : 10.2174/1389201021666200109104701

  Journal Home
Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Lactic acid bacteria are beneficial to human health. Lactic acid bacteria have wide applications in food, cosmetic and medicine industries due to being Generally Recognized As Safe (GRAS) and a multitude of therapeutic and functional properties. Previous studies have reported the beneficial effects of lactic acid bacteria, their extracts or ferments on skin health, including improvements in skin conditions and the prevention of skin diseases. Lipoteichoic acid isolated from Lactobacillus plantarum was reported to inhibit melanogenesis in B16F10 melanoma cells. In particular, lipoteichoic acid also exerted anti-photoaging effects on human skin cells by regulating the expression of matrix metalloproteinase- 1. The oral administration of Lactobacillus delbrueckii and other lactic acid bacteria has been reported to inhibit the development of atopic diseases. Additionally, the clinical and histologic evidence indicates that the topical application of lactic acid is effective for depigmentation and improving the surface roughness and mild wrinkling of the skin caused by environmental photo-damage. This review discusses recent findings on the effects of lactic acid bacteria on skin health and their specific applications in skin-whitening cosmetics.

Keywords: Lactic acid bacteria, skin, photo-damage, melanogenesis, cosmetic, lipoteichoic acid.

[1]
Isolauri, E. Probiotics in the prevention and treatment of allergic disease. Pediatr. Allergy Immunol., 2001, 12(Suppl. 14), 56-59.
[http://dx.doi.org/10.1034/j.1399-3038.2001.121413.x] [PMID: 11380901]
[2]
Isolauri, E.; Sütas, Y.; Kankaanpää, P.; Arvilommi, H.; Salminen, S. Probiotics: effects on immunity. Am. J. Clin. Nutr., 2001, 73(2)(Suppl.), 444S-450S.
[http://dx.doi.org/10.1093/ajcn/73.2.444s] [PMID: 11157355]
[3]
Mohan, R.; Koebnick, C.; Schildt, J.; Schmidt, S.; Mueller, M.; Possner, M.; Radke, M.; Blaut, M. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J. Clin. Microbiol., 2006, 44(11), 4025-4031.
[http://dx.doi.org/10.1128/JCM.00767-06] [PMID: 16971641]
[4]
Bernet-Camard, M.F.; Liévin, V.; Brassart, D.; Neeser, J.R.; Servin, A.L.; Hudault, S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol., 1997, 63(7), 2747-2753.
[PMID: 9212421]
[5]
Coconnier, M-H.; Lievin, V.; Hemery, E.; Servin, A.L. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol., 1998, 64(11), 4573-4580.
[http://dx.doi.org/10.1128/AEM.64.11.4573-4580.1998] [PMID: 9797324]
[6]
Habil, N.; Al-Murrani, W.; Beal, J.; Foey, A.D. Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner. Benef. Microbes, 2011, 2(4), 283-293.
[http://dx.doi.org/10.3920/BM2011.0027] [PMID: 22146688]
[7]
Ouwehand, A.C.; Salminen, S.; Isolauri, E. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek, 2002, 82(1-4), 279-289.
[http://dx.doi.org/10.1023/A:1020620607611] [PMID: 12369194]
[8]
Parvez, S.; Malik, K.A.; Ah Kang, S.; Kim, H-Y. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol., 2006, 100(6), 1171-1185.
[http://dx.doi.org/10.1111/j.1365-2672.2006.02963.x] [PMID: 16696665]
[9]
Coconnier, M-H.; Bernet, M-F.; Kernéis, S.; Chauvière, G.; Fourniat, J.; Servin, A.L. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett., 1993, 110(3), 299-305.
[http://dx.doi.org/10.1111/j.1574-6968.1993.tb06339.x] [PMID: 8354463]
[10]
Cotter, P.D.; Hill, C.; Ross, R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol., 2005, 3(10), 777-788.
[http://dx.doi.org/10.1038/nrmicro1273] [PMID: 16205711]
[11]
Karska-Wysocki, B.; Bazo, M.; Smoragiewicz, W. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol. Res., 2010, 165(8), 674-686.
[http://dx.doi.org/10.1016/j.micres.2009.11.008] [PMID: 20116228]
[12]
Mack, D.R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol., 1999, 276(4), G941-G950.
[PMID: 10198338]
[13]
Ron, E.Z.; Rosenberg, E. Natural roles of biosurfactants. Environ. Microbiol., 2001, 3(4), 229-236.
[http://dx.doi.org/10.1046/j.1462-2920.2001.00190.x] [PMID: 11359508]
[14]
Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet, 2001, 357(9262), 1076-1079.
[http://dx.doi.org/10.1016/S0140-6736(00)04259-8] [PMID: 11297958]
[15]
Rautava, S.; Isolauri, E. The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Curr. Issues Intest. Microbiol., 2002, 3(1), 15-22.
[PMID: 12022809]
[16]
Bernardeau, M.; Vernoux, J.P.; Henri-Dubernet, S.; Guéguen, M. Safety assessment of dairy microorganisms: the Lactobacillus genus. Int. J. Food Microbiol., 2008, 126(3), 278-285.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2007.08.015] [PMID: 17889388]
[17]
Mayrhofer, S.; Domig, K.J.; Mair, C.; Zitz, U.; Huys, G.; Kneifel, W. Comparison of broth microdilution, Etest, and agar disk diffusion methods for antimicrobial susceptibility testing of Lactobacillus acidophilus group members. Appl. Environ. Microbiol., 2008, 74(12), 3745-3748.
[http://dx.doi.org/10.1128/AEM.02849-07] [PMID: 18441109]
[18]
Scharffetter-Kochanek, K.; Brenneisen, P.; Wenk, J.; Herrmann, G.; Ma, W.; Kuhr, L.; Meewes, C.; Wlaschek, M. Photoaging of the skin from phenotype to mechanisms. Exp. Gerontol., 2000, 35(3), 307-316.
[http://dx.doi.org/10.1016/S0531-5565(00)00098-X] [PMID: 10832052]
[19]
Salminen, S.J.; Gueimonde, M.; Isolauri, E. Probiotics that modify disease risk. J. Nutr., 2005, 135(5), 1294-1298.
[http://dx.doi.org/10.1093/jn/135.5.1294] [PMID: 15867327]
[20]
Seité, S.; Zucchi, H.; Moyal, D.; Tison, S.; Compan, D.; Christiaens, F.; Guéniche, A.; Fourtanier, A. Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br. J. Dermatol., 2003, 148(2), 291-299.
[http://dx.doi.org/10.1046/j.1365-2133.2003.05112.x] [PMID: 12588382]
[21]
Ullrich, S.E. Mechanisms underlying UV-induced immune suppression. Mutat. Res., 2005, 571(1-2), 185-205.
[http://dx.doi.org/10.1016/j.mrfmmm.2004.06.059] [PMID: 15748647]
[22]
Cruchet, S.; Obregon, M.C.; Salazar, G.; Diaz, E.; Gotteland, M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition, 2003, 19(9), 716-721.
[http://dx.doi.org/10.1016/S0899-9007(03)00109-6] [PMID: 12921879]
[23]
Timmerman, H.M.; Koning, C.J.; Mulder, L.; Rombouts, F.M.; Beynen, A.C. Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy. Int. J. Food Microbiol., 2004, 96(3), 219-233.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2004.05.012] [PMID: 15454313]
[24]
Nguyen, T.D.T.; Kang, J.H.; Lee, M.S. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int. J. Food Microbiol., 2007, 113(3), 358-361.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2006.08.015] [PMID: 17140690]
[25]
Jain, S.; Yadav, H.; Sinha, P.R. Stimulation of innate immunity by oral administration of dahi containing probiotic Lactobacillus casei in mice. J. Med. Food, 2008, 11(4), 652-656.
[http://dx.doi.org/10.1089/jmf.2006.0132] [PMID: 19053856]
[26]
Commane, D.; Hughes, R.; Shortt, C.; Rowland, I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat. Res., 2005, 591(1-2), 276-289.
[http://dx.doi.org/10.1016/j.mrfmmm.2005.02.027] [PMID: 16095630]
[27]
Liang, T-W.; Wu, Y-Y.; Huang, T-Y.; Wang, C-Y.; Yen, Y-H.; Liu, C-P.; Chen, Y-C.; Wang, S-L. Conversion of squid pen by a novel strain Lactobacillus paracasei subsp. paracasei TKU010, and its application in antimicrobial and antioxidants activity. J. Gen. Appl. Microbiol., 2010, 56(6), 481-489.
[http://dx.doi.org/10.2323/jgam.56.481] [PMID: 21282904]
[28]
De Keersmaecker, S.C.; Verhoeven, T.L.; Desair, J.; Marchal, K.; Vanderleyden, J.; Nagy, I. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol. Lett., 2006, 259(1), 89-96.
[http://dx.doi.org/10.1111/j.1574-6968.2006.00250.x] [PMID: 16684107]
[29]
Varma, P.; Nisha, N.; Dinesh, K.R.; Kumar, A.V.; Biswas, R. Anti-infective properties of Lactobacillus fermentum against Staphylococcus aureus and Pseudomonas aeruginosa. J. Mol. Microbiol. Biotechnol., 2011, 20(3), 137-143.
[http://dx.doi.org/10.1159/000328512] [PMID: 21701187]
[30]
Tsai, C.C.; Lin, P.P.; Hsieh, Y.M. Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. Anaerobe, 2008, 14(2), 61-67.
[http://dx.doi.org/10.1016/j.anaerobe.2007.11.003] [PMID: 18182312]
[31]
Pathak, M.A. Sunscreens: topical and systemic approaches for protection of human skin against harmful effects of solar radiation. J. Am. Acad. Dermatol., 1982, 7(3), 285-312.
[http://dx.doi.org/10.1016/S0190-9622(82)70117-3] [PMID: 6752223]
[32]
McCallion, R.; Li Wan Po, A. Dry and photo-aged skin: manifestations and management. J. Clin. Pharm. Ther., 1993, 18(1), 15-32.
[http://dx.doi.org/10.1111/j.1365-2710.1993.tb00562.x] [PMID: 8473356]
[33]
Fabbrocini, G.; Bertona, M.; Picazo, Ó.; Pareja-Galeano, H.; Monfrecola, G.; Emanuele, E. Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne. Benef. Microbes, 2016, 7(5), 625-630.
[http://dx.doi.org/10.3920/BM2016.0089] [PMID: 27596801]
[34]
Smith, W.P. Comparative effectiveness of α-hydroxy acids on skin properties. Int. J. Cosmet. Sci., 1996, 18(2), 75-83.
[http://dx.doi.org/10.1111/j.1467-2494.1996.tb00137.x] [PMID: 19245467]
[35]
Hsiao, Y-P.; Huang, H-L.; Lai, W-W.; Chung, J-G.; Yang, J-H. Antiproliferative effects of lactic acid via the induction of apoptosis and cell cycle arrest in a human keratinocyte cell line (HaCaT). J. Dermatol. Sci., 2009, 54(3), 175-184.
[http://dx.doi.org/10.1016/j.jdermsci.2009.02.012] [PMID: 19339159]
[36]
Ai, C.; Ma, N.; Zhang, Q.; Wang, G.; Liu, X.; Tian, F.; Chen, P.; Chen, W. Immunomodulatory effects of different lactic acid bacteria on allergic response and its relationship with in vitro properties. PLoS One, 2016, 11(10)e0164697
[http://dx.doi.org/10.1371/journal.pone.0164697] [PMID: 27764153]
[37]
Mijouin, L.; Hillion, M.; Ramdani, Y.; Jaouen, T.; Duclairoir-Poc, C.; Follet-Gueye, M-L.; Lati, E.; Yvergnaux, F.; Driouich, A.; Lefeuvre, L.; Farmer, C.; Misery, L.; Feuilloley, M.G.J. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One, 2013, 8(11)e78773
[http://dx.doi.org/10.1371/journal.pone.0078773] [PMID: 24250813]
[38]
Margolis, K.G.; Gershon, M.D. Neuropeptides and inflammatory bowel disease. Curr. Opin. Gastroenterol., 2009, 25(6), 503-511.
[http://dx.doi.org/10.1097/MOG.0b013e328331b69e] [PMID: 19816171]
[39]
Biaggini, K.; Borrel, V.; Szunerits, S.; Boukherroub, R.; N’Diaye, A.; Zébré, A.; Bonnin-Jusserand, M.; Duflos, G.; Feuilloley, M.; Drider, D.; Déchelotte, P.; Connil, N. Substance P enhances lactic acid and tyramine production in Enterococcus faecalis V583 and promotes its cytotoxic effect on intestinal Caco-2/TC7 cells. Gut Pathog., 2017, 9(1), 20.
[http://dx.doi.org/10.1186/s13099-017-0171-3] [PMID: 28439299]
[40]
Iozumi, K.; Hoganson, G.E.; Pennella, R.; Everett, M.A.; Fuller, B.B. Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J. Invest. Dermatol., 1993, 100(6), 806-811.
[http://dx.doi.org/10.1111/1523-1747.ep12476630] [PMID: 8496620]
[41]
Usuki, A.; Ohashi, A.; Sato, H.; Ochiai, Y.; Ichihashi, M.; Funasaka, Y. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp. Dermatol., 2003, 12(s2)(Suppl. 2), 43-50.
[http://dx.doi.org/10.1034/j.1600-0625.12.s2.7.x] [PMID: 14756523]
[42]
Draelos, Z.D. Skin lightening preparations and the hydroquinone controversy. Dermatol. Ther., 2007, 20(5), 308-313.
[http://dx.doi.org/10.1111/j.1529-8019.2007.00144.x] [PMID: 18045355]
[43]
Kim, H.R.; Kim, H.; Jung, B.J.; You, G.E.; Jang, S.; Chung, D.K. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits melanogenesis in B16F10 mouse melanoma cells. Mol. Cells, 2015, 38(2), 163-170.
[PMID: 26021887]
[44]
Slominski, A.; Tobin, D.J.; Shibahara, S.; Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev., 2004, 84(4), 1155-1228.
[http://dx.doi.org/10.1152/physrev.00044.2003] [PMID: 15383650]
[45]
Pawelek, J.M.; Chakraborty, A.K. The enzymology of melanogenesis. The Pigmentary System: Physiology and Pathophysiology; Nordlund, J.J.; Boissy, R.E.; Hearing, V.J.; King, R.A.; Ortonne, JP., Eds.; Oxford University Press: New York, Oxford, 1998, pp. 391-400.
[46]
Lee, J.; Jung, K.; Kim, Y.S.; Park, D. Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sci., 2007, 81(3), 249-254.
[http://dx.doi.org/10.1016/j.lfs.2007.05.009] [PMID: 17568620]
[47]
Englaro, W.; Bertolotto, C.; Buscà, R.; Brunet, A.; Pagès, G.; Ortonne, J.P.; Ballotti, R. Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J. Biol. Chem., 1998, 273(16), 9966-9970.
[http://dx.doi.org/10.1074/jbc.273.16.9966] [PMID: 9545341]
[48]
Su, T.R.; Lin, J.J.; Tsai, C.C.; Huang, T.K.; Yang, Z.Y.; Wu, M.O.; Zheng, Y.Q.; Su, C.C.; Wu, Y.J. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int. J. Mol. Sci., 2013, 14(10), 20443-20458.
[http://dx.doi.org/10.3390/ijms141020443] [PMID: 24129178]
[49]
Kawano, M.; Matsuyama, K.; Miyamae, Y.; Shinmoto, H.; Kchouk, M.E.; Morio, T.; Shigemori, H.; Isoda, H. Antimelanogenesis effect of Tunisian herb Thymelaea hirsuta extract on B16 murine melanoma cells. Exp. Dermatol., 2007, 16(12), 977-984.
[http://dx.doi.org/10.1111/j.1600-0625.2007.00618.x] [PMID: 18031456]
[50]
Buscà, R.; Ballotti, R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res., 2000, 13(2), 60-69.
[http://dx.doi.org/10.1034/j.1600-0749.2000.130203.x] [PMID: 10841026]
[51]
Bertolotto, C.; Buscà, R.; Abbe, P.; Bille, K.; Aberdam, E.; Ortonne, J-P.; Ballotti, R. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol. Cell. Biol., 1998, 18(2), 694-702.
[http://dx.doi.org/10.1128/MCB.18.2.694] [PMID: 9447965]
[52]
Kim, H.G.; Kim, N-R.; Gim, M.G.; Lee, J.M.; Lee, S.Y.; Ko, M.Y.; Kim, J.Y.; Han, S.H.; Chung, D.K. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-α production in THP-1 cells and endotoxin shock in mice. J. Immunol., 2008, 180(4), 2553-2561.
[http://dx.doi.org/10.4049/jimmunol.180.4.2553] [PMID: 18250466]
[53]
Rosenfeldt, V.; Benfeldt, E.; Nielsen, S.D.; Michaelsen, K.F.; Jeppesen, D.L.; Valerius, N.H.; Paerregaard, A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol., 2003, 111(2), 389-395.
[http://dx.doi.org/10.1067/mai.2003.389] [PMID: 12589361]
[54]
Goto, K.; Iwasawa, D.; Kamimura, Y.; Yasuda, M.; Matsumura, M.; Shimada, T. Clinical and histopathological evaluation of Dermatophagoides farinae-induced dermatitis in NC/Nga mice orally administered Bacillus subtilis. J. Vet. Med. Sci., 2011, 73(5), 649-654.
[http://dx.doi.org/10.1292/jvms.10-0457] [PMID: 21206175]
[55]
Guéniche, A.; Benyacoub, J.; Buetler, T.M.; Smola, H.; Blum, S. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur. J. Dermatol., 2006, 16(5), 511-517.
[PMID: 17101471]
[56]
Guéniche, A.; Philippe, D.; Bastien, P.; Blum, S.; Buyukpamukcu, E.; Castiel-Higounenc, I. Probiotics for photoprotection. Dermatoendocrinol, 2009, 1(5), 275-279.
[http://dx.doi.org/10.4161/derm.1.5.9849] [PMID: 20808516]
[57]
Philippe, D.; Blum, S.; Benyacoub, J. Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation. Eur. J. Dermatol., 2011, 21(2), 279-280.
[http://dx.doi.org/10.1684/ejd.2010.1242] [PMID: 21489918]
[58]
Watanabe, T.; Hamada, K.; Tategaki, A.; Kishida, H.; Tanaka, H.; Kitano, M.; Miyamoto, T. Oral administration of lactic acid bacteria isolated from traditional South Asian fermented milk ‘dahi’ inhibits the development of atopic dermatitis in NC/Nga mice. J. Nutr. Sci. Vitaminol. (Tokyo), 2009, 55(3), 271-278.
[http://dx.doi.org/10.3177/jnsv.55.271] [PMID: 19602836]
[59]
Leyden, J.J.; McGinley, K.J.; Nordstrom, K.M.; Webster, G.F. Skin microflora. J. Invest. Dermatol., 1987, 88(3)(Suppl.), 65s-72s.
[http://dx.doi.org/10.1111/1523-1747.ep12468965] [PMID: 3102625]
[60]
Prince, T.; McBain, A.J.; O’Neill, C.A. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion. Appl. Environ. Microbiol., 2012, 78(15), 5119-5126.
[http://dx.doi.org/10.1128/AEM.00595-12] [PMID: 22582077]
[61]
Cinque, B.; Di Marzio, L.; Della Riccia, D.N.; Bizzini, F.; Giuliani, M.; Fanini, D.; De Simone, C.; Cifone, M.G. Effect of Bifidobacterium infantis on Interferon- γ- induced keratinocyte apoptosis: a potential therapeutic approach to skin immune abnormalities. Int. J. Immunopathol. Pharmacol., 2006, 19(4), 775-786.
[http://dx.doi.org/10.1177/039463200601900407] [PMID: 17166399]
[62]
Zhu, D-L.; Yang, W-X.; Yang, H-M. [Meta analysis of lactic acid bacteria as probiotics for the primary prevention of infantile eczema]. Zhongguo Dang Dai Er Ke Za Zhi, 2010, 12(9), 734-739.
[PMID: 20849726]
[63]
Oh, J.; Yu, T.; Choi, S.J.; Yang, Y.; Baek, H.S.; An, S.A.; Kwon, L.K.; Kim, J.; Rho, H.S.; Shin, S.S.; Choi, W.S.; Hong, S.; Cho, J.Y. Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid. Mediators Inflamm., 2012, 2012781375
[http://dx.doi.org/10.1155/2012/781375] [PMID: 22577255]
[64]
Ghadimi, D.; de Vrese, M.; Heller, K.J.; Schrezenmeir, J. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-γ) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen. Int. Immunopharmacol., 2010, 10(6), 694-706.
[http://dx.doi.org/10.1016/j.intimp.2010.03.014] [PMID: 20381647]
[65]
Oh, Y-C.; Cho, W-K.; Oh, J.H.; Im, G.Y.; Jeong, Y.H.; Yang, M.C.; Ma, J.Y. Fermentation by Lactobacillus enhances anti-inflammatory effect of Oyaksungisan on LPS-stimulated RAW 264.7 mouse macrophage cells. BMC Complement. Altern. Med., 2012, 12(1), 17.
[http://dx.doi.org/10.1186/1472-6882-12-17] [PMID: 22405334]
[66]
Yang, Y-J.; Chuang, C-C.; Yang, H-B.; Lu, C-C.; Sheu, B-S. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathways. BMC Microbiol., 2012, 12(1), 38.
[http://dx.doi.org/10.1186/1471-2180-12-38] [PMID: 22429929]
[67]
Guéniche, A.; Benyacoub, J.; Philippe, D.; Bastien, P.; Kusy, N.; Breton, L.; Blum, S.; Castiel-Higounenc, I. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur. J. Dermatol., 2010, 20(6), 731-737.
[PMID: 20965806]
[68]
Prescott, S.L.; Dunstan, J.A.; Hale, J.; Breckler, L.; Lehmann, H.; Weston, S.; Richmond, P. Clinical effects of probiotics are associated with increased interferon-γ responses in very young children with atopic dermatitis. Clin. Exp. Allergy, 2005, 35(12), 1557-1564.
[http://dx.doi.org/10.1111/j.1365-2222.2005.02376.x] [PMID: 16393321]
[69]
Hacini-Rachinel, F.; Gheit, H.; Le Luduec, J-B.; Dif, F.; Nancey, S.; Kaiserlian, D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One, 2009, 4(3)e4903
[http://dx.doi.org/10.1371/journal.pone.0004903] [PMID: 19300508]
[70]
Banerjee, P.; Merkel, G.J.; Bhunia, A.K. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog., 2009, 1(1), 8.
[http://dx.doi.org/10.1186/1757-4749-1-8] [PMID: 19397787]
[71]
Wanke, I.; Steffen, H.; Christ, C.; Krismer, B.; Götz, F.; Peschel, A.; Schaller, M.; Schittek, B. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Invest. Dermatol., 2011, 131(2), 382-390.
[http://dx.doi.org/10.1038/jid.2010.328] [PMID: 21048787]
[72]
Burkhart, C.N.; Burkhart, C.G. Microbiology’s principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int. J. Dermatol., 2003, 42(12), 925-927.
[http://dx.doi.org/10.1111/j.1365-4632.2003.01588.x] [PMID: 14636182]
[73]
Lai, Y.; Di Nardo, A.; Nakatsuji, T.; Leichtle, A.; Yang, Y.; Cogen, A.L.; Wu, Z-R.; Hooper, L.V.; Schmidt, R.R.; von Aulock, S.; Radek, K.A.; Huang, C-M.; Ryan, A.F.; Gallo, R.L. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med., 2009, 15(12), 1377-1382.
[http://dx.doi.org/10.1038/nm.2062] [PMID: 19966777]
[74]
Peral, M.C.; Rachid, M.M.; Gobbato, N.M.; Huaman Martinez, M.A.; Valdez, J.C. Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin. Microbiol. Infect., 2010, 16(3), 281-286.
[http://dx.doi.org/10.1111/j.1469-0691.2009.02793.x] [PMID: 19519855]
[75]
Farmer, S.; Mikhail, R.J. Topical use of probiotic bacillus spores to prevent or control microbial infections. WO Patent 047374, 1998.
[76]
Levkovich, T.; Poutahidis, T.; Smillie, C.; Varian, B.J.; Ibrahim, Y.M.; Lakritz, J.R.; Alm, E.J.; Erdman, S.E. Probiotic bacteria induce a ‘glow of health’. PLoS One, 2013, 8(1)e53867
[http://dx.doi.org/10.1371/journal.pone.0053867] [PMID: 23342023]
[77]
Al-Ghazzewi, F.H.; Tester, R.F. Impact of prebiotics and probiotics on skin health. Benef. Microbes, 2014, 5(2), 99-107.
[http://dx.doi.org/10.3920/BM2013.0040] [PMID: 24583611]
[78]
Guéniche, A.; Hennino, A.; Goujon, C.; Dahel, K.; Bastien, P.; Martin, R.; Jourdain, R.; Breton, L. Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur. J. Dermatol., 2006, 16(4), 380-384.
[PMID: 16935794]
[79]
Guéniche, A.; Bastien, P.; Ovigne, J.M.; Kermici, M.; Courchay, G.; Chevalier, V.; Breton, L.; Castiel-Higounenc, I. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol., 2010, 19(8), e1-e8.
[http://dx.doi.org/10.1111/j.1600-0625.2009.00932.x] [PMID: 19624730]
[80]
Stokes, J.H.; Pillsbury, D.M. The effect on the skin of emotional and nervous states: Iii. theoretical and practical consideration of a gastro-intestinal mechanism. Arch. Derm. Syphilol., 1930, 22(6), 962-993.
[http://dx.doi.org/10.1001/archderm.1930.01440180008002]
[81]
Segawa, S.; Hayashi, A.; Nakakita, Y.; Kaneda, H.; Watari, J.; Yasui, H. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biol. Pharm. Bull., 2008, 31(5), 884-889.
[http://dx.doi.org/10.1248/bpb.31.884] [PMID: 18451512]
[82]
Kim, H.H.; Lee, Y.; Eun, H.C.; Chung, J.H. Eicosapentaenoic acid inhibits TNF-α-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells. Biochem. Biophys. Res. Commun., 2008, 368(2), 343-349.
[http://dx.doi.org/10.1016/j.bbrc.2008.01.062] [PMID: 18222174]
[83]
Weston, S.; Halbert, A.; Richmond, P.; Prescott, S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child., 2005, 90(9), 892-897.
[http://dx.doi.org/10.1136/adc.2004.060673] [PMID: 15863468]
[84]
Guéniche, A.; Philippe, D.; Bastien, P.; Reuteler, G.; Blum, S.; Castiel-Higounenc, I.; Breton, L.; Benyacoub, J. Randomised double-blind placebo-controlled study of the effect of Lactobacillus paracasei NCC 2461 on skin reactivity. Benef. Microbes, 2014, 5(2), 137-145.
[http://dx.doi.org/10.3920/BM2013.0001] [PMID: 24322879]
[85]
Abrahamsson, T.R.; Jakobsson, T.; Böttcher, M.F.; Fredrikson, M.; Jenmalm, M.C.; Björkstén, B.; Oldaeus, G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol., 2007, 119(5), 1174-1180.
[http://dx.doi.org/10.1016/j.jaci.2007.01.007] [PMID: 17349686]
[86]
Park, C.W.; Youn, M.; Jung, Y-M.; Kim, H.; Jeong, Y.; Lee, H-K.; Kim, H.O.; Lee, I.; Lee, S.W.; Kang, K.H.; Park, Y-H. New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J. Med. Food, 2008, 11(3), 405-412.
[http://dx.doi.org/10.1089/jmf.2007.0144] [PMID: 18800885]
[87]
Elbe-Bürger, A.; Egyed, A.; Olt, S.; Klubal, R.; Mann, U.; Rappersberger, K.; Rot, A.; Stingl, G. Overexpression of IL-4 alters the homeostasis in the skin. J. Invest. Dermatol., 2002, 118(5), 767-778.
[http://dx.doi.org/10.1046/j.1523-1747.2002.01753.x] [PMID: 11982753]
[88]
Isolauri, E.; Arvola, T.; Sütas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy, 2000, 30(11), 1604-1610.
[http://dx.doi.org/10.1046/j.1365-2222.2000.00943.x] [PMID: 11069570]
[89]
Vishnu, C.; Seenayya, G.; Reddy, G. Direct conversion of starch to L(+) lactic acid by amylase producing Lactobacillus amylophilus GV6. Bioprocess Eng., 2000, 23(2), 155-158.
[http://dx.doi.org/10.1007/PL00009119]
[90]
Burgos-Rubio, C.N.; Okos, M.R.; Wankat, P.C. Kinetic study of the conversion of different substrates to lactic acid using Lactobacillus bulgaricus. Biotechnol. Prog., 2000, 16(3), 305-314.
[http://dx.doi.org/10.1021/bp000022p] [PMID: 10835228]
[91]
Ding, S.; Tan, T. l-lactic acid production by Lactobacillus casei fermentation using different fed-batch feeding strategies. Process Biochem., 2006, 41(6), 1451-1454.
[http://dx.doi.org/10.1016/j.procbio.2006.01.014]
[92]
Hujanen, M.; Linko, S.; Linko, Y-Y.; Leisola, M. Optimisation of media and cultivation conditions for L(+)(S)-lactic acid production by Lactobacillus casei NRRL B-441. Appl. Microbiol. Biotechnol., 2001, 56(1-2), 126-130.
[http://dx.doi.org/10.1007/s002530000501] [PMID: 11499919]
[93]
Nancib, A.; Nancib, N.; Boubendir, A.; Boudrant, J. The use of date waste for lactic acid production by a fed-batch culture using Lactobacillus casei subsp. rhamnosus. Braz. J. Microbiol., 2015, 46(3), 893-902.
[http://dx.doi.org/10.1590/S1517-838246320131067] [PMID: 26413076]
[94]
Kotzamanidis, C.; Roukas, T.; Skaracis, G. Optimization of lactic acid production from beet molasses by Lactobacillus delbrueckii NCIMB 8130. World J. Microbiol. Biotechnol., 2002, 18(5), 441-448.
[http://dx.doi.org/10.1023/A:1015523126741]
[95]
Willem Schepers, A.; Thibault, J.; Lacroix, C. Lactobacillus helveticus growth and lactic acid production during pH-controlled batch cultures in whey permeate/yeast extract medium. Part I. multiple factor kinetic analysis. Enzyme Microb. Technol., 2002, 30(2), 176-186.
[http://dx.doi.org/10.1016/S0141-0229(01)00465-3]
[96]
Moon, S-K.; Wee, Y-J.; Choi, G-W. A novel lactic acid bacterium for the production of high purity L-lactic acid, Lactobacillus paracasei subsp. paracasei CHB2121. J. Biosci. Bioeng., 2012, 114(2), 155-159.
[http://dx.doi.org/10.1016/j.jbiosc.2012.03.016] [PMID: 22578598]
[97]
Bustos, G.; Moldes, A.B.; Cruz, J.M.; Domínguez, J.M. Production of fermentable media from vine-trimming wastes and bioconversion into lactic acid by Lactobacillus pentosus. J. Sci. Food Agric., 2004, 84(15), 2105-2112.
[http://dx.doi.org/10.1002/jsfa.1922]
[98]
Hu, J.; Lin, Y.; Zhang, Z.; Xiang, T.; Mei, Y.; Zhao, S.; Liang, Y.; Peng, N. High-titer lactic acid production by Lactobacillus pentosus FL0421 from corn stover using fed-batch simultaneous saccharification and fermentation. Bioresour. Technol., 2016, 214, 74-80.
[http://dx.doi.org/10.1016/j.biortech.2016.04.034] [PMID: 27128191]
[99]
Hama, S.; Mizuno, S.; Kihara, M.; Tanaka, T.; Ogino, C.; Noda, H.; Kondo, A. Production of d-lactic acid from hardwood pulp by mechanical milling followed by simultaneous saccharification and fermentation using metabolically engineered Lactobacillus plantarum. Bioresour. Technol., 2015, 187, 167-172.
[http://dx.doi.org/10.1016/j.biortech.2015.03.106] [PMID: 25846187]
[100]
Fu, W.; Mathews, A.P. Lactic acid production from lactose by Lactobacillus plantarum: Kinetic model and effects of pH, substrate, and oxygen. Biochem. Eng. J., 1999, 3(3), 163-170.
[http://dx.doi.org/10.1016/S1369-703X(99)00014-5]
[101]
Berry, A.R.; Franco, C.M.M.; Zhang, W.; Middelberg, A.P.J. Growth and lactic acid production in batch culture of Lactobacillus rhamnosus in a defined medium. Biotechnol. Lett., 1999, 21(2), 163-167.
[http://dx.doi.org/10.1023/A:1005483609065]
[102]
Bernardo, M.P.; Coelho, L.F.; Sass, D.C.; Contiero, J. l-(+)-Lactic acid production by Lactobacillus rhamnosus B103 from dairy industry waste. Braz. J. Microbiol., 2016, 47(3), 640-646.
[http://dx.doi.org/10.1016/j.bjm.2015.12.001] [PMID: 27266630]
[103]
Roble, N.D.; Ogbonna, J.C.; Tanaka, H. L-Lactic acid production from raw cassava starch in a circulating loop bioreactor with cells immobilized in loofa (Luffa cylindrica). Biotechnol. Lett., 2003, 25(13), 1093-1098.
[http://dx.doi.org/10.1023/A:1024192131343] [PMID: 12889820]
[104]
Ditre, C.M.; Griffin, T.D.; Murphy, G.F.; Sueki, H.; Telegan, B.; Johnson, W.C.; Yu, R.J.; Van Scott, E.J. Effects of α-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J. Am. Acad. Dermatol., 1996, 34(2 Pt 1), 187-195.
[http://dx.doi.org/10.1016/S0190-9622(96)80110-1] [PMID: 8642081]
[105]
Rubin, M.G. The clinical use of alpha hydroxy acids. Australas. J. Dermatol., 1994, 35(1), 29-33.
[http://dx.doi.org/10.1111/j.1440-0960.1994.tb01797.x] [PMID: 7998897]
[106]
Van Scott, E.J.; Yu, R.J. Alpha hydroxy acids: procedures for use in clinical practice. Cutis, 1989, 43(3), 222-228.
[PMID: 2523288]
[107]
Smith, W.P. The effects of topical l(+) lactic Acid and ascorbic Acid on skin whitening. Int. J. Cosmet. Sci., 1999, 21(1), 33-40.
[http://dx.doi.org/10.1046/j.1467-2494.1999.196561.x] [PMID: 18505528]
[108]
Ando, S.; Ando, O.; Suemoto, Y.; Mishima, Y. Tyrosinase gene transcription and its control by melanogenic inhibitors. J. Invest. Dermatol., 1993, 100(2)(Suppl.), 150S-155S.
[http://dx.doi.org/10.1038/jid.1993.68] [PMID: 8433001]
[109]
Hasan, M.Z.; Kitamura, M.; Kawai, M.; Ohira, M.; Mori, K.; Shoju, S.; Takagi, K.; Tsukamoto, K.; Kawai, Y.; Inoue, A. Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol. In Vitro, 2019, 57, 164-173.
[http://dx.doi.org/10.1016/j.tiv.2019.03.005] [PMID: 30851411]
[110]
Tasic-Kostov, M.; Savic, S.; Lukic, M.; Tamburic, S.; Pavlovic, M.; Vuleta, G. Lactobionic acid in a natural alkylpolyglucoside-based vehicle: assessing safety and efficacy aspects in comparison to glycolic acid. J. Cosmet. Dermatol., 2010, 9(1), 3-10.
[http://dx.doi.org/10.1111/j.1473-2165.2010.00474.x] [PMID: 20367666]
[111]
https://cosmetics.specialchem.com/product/i-a-pep-apep-ferment-citrus
[112]
SpecialChem. Apep Ferment collagen., https://cosmetics.specialchem.com/product/i-a-pep-apep-ferment-collagen
[113]
SpecialChem. https://cosmetics.specialchem.com/product/i-a-pep-tranexell-v10
[114]
SpecialChem. https://cosmetics.specialchem.com/product/i-active-micro-technologies-leucidal-liquid-complete
[115]
SpecialChem. https://cosmetics.specialchem.com/product/i-active-micro-technologies-leucidal-sf-complete
[116]
SpecialChem. https://cosmetics.specialchem.com/product/i-morechem-lactobacillus
[117]
SpecialChem. https://cosmetics.specialchem.com/product/i-solabia-ecoskin
[118]
Castiel, I.; Gueniche, A. Cosmetic use of Lactobacillus paracasei for the treatment of oily skin. E.P. Patent 230,6970B1, 2014.
[119]
Sullivan, M.; Schnittger, S.F.; Mammone, T.; Goyarts, E.C. Skin treatment method with Lactobacillus extract. U.S. Patent 7510734B2 2009.
[120]
Isabelle, C.; Audrey, G. Cosmetic and dermatological use of probiotic Lactobacillus paracasei microorganisms for the treatment of greasy scalp disorders. E.P. Patent 214,9368A1 2010.
[121]
Audrey, G.; Isabelle, C. Cosmetic use of at least one probiotic microorganism, especially of the Lactobacillus genus sp.e cosmetic process. U. S. Patent 112,012013722A2 2017.
[122]
Wang, C-L.; Huang, T-H.; Liang, T-W.; Fang, C-Y.; Wang, S-L. Production and characterization of exopolysaccharides and antioxidant from Paenibacillus sp. TKU023. N. Biotechnol., 2011, 28(6), 559-565.
[http://dx.doi.org/10.1016/j.nbt.2011.03.003] [PMID: 21402186]
[123]
Górska, S.; Jachymek, W.; Rybka, J.; Strus, M.; Heczko, P.B.; Gamian, A. Structural and immunochemical studies of neutral exopolysaccharide produced by Lactobacillus johnsonii 142. Carbohydr. Res., 2010, 345(1), 108-114.
[http://dx.doi.org/10.1016/j.carres.2009.09.015] [PMID: 19897181]
[124]
Ramchandran, L.; Shah, N.P. Effect of exopolysaccharides and inulin on the proteolytic, angiotensin-I-converting enzyme-and α-glucosidase-inhibitory activities as well as on textural and rheological properties of low-fat yogurt during refrigerated storage. Dairy Sci. Technol., 2009, 89(6), 583-600.
[http://dx.doi.org/10.1051/dst/2009039]
[125]
Tsai, C-C.; Chan, C-F.; Huang, W-Y.; Lin, J-S.; Chan, P.; Liu, H-Y.; Lin, Y-S. Applications of Lactobacillus rhamnosus spent culture supernatant in cosmetic antioxidation, whitening and moisture retention applications. Molecules, 2013, 18(11), 14161-14171.
[http://dx.doi.org/10.3390/molecules181114161] [PMID: 24248144]
[126]
Kawagishi, H.; Somoto, A.; Kuranari, J.; Kimura, A.; Chiba, S. A novel cyclotetrapeptide produced by Lactobacillus helveticus as a tyrosinase inhibitor. Tetrahedron Lett., 1993, 34(21), 3439-3440.
[http://dx.doi.org/10.1016/S0040-4039(00)79177-5]
[127]
Chen, Y-M.; Shih, T-W.; Chiu, C.P.; Pan, T-M.; Tsai, T-Y. Effects of lactic acid bacteria-fermented soy milk on melanogenesis in B16F0 melanocytes. J. Funct. Foods, 2013, 5(1), 395-405.
[http://dx.doi.org/10.1016/j.jff.2012.11.012]
[128]
Rong, J.; Shan, C.; Liu, S.; Zheng, H.; Liu, C.; Liu, M.; Jin, F.; Wang, L. Skin resistance to UVB-induced oxidative stress and hyperpigmentation by the topical use of Lactobacillus helveticus NS8-fermented milk supernatant. J. Appl. Microbiol., 2017, 123(2), 511-523.
[http://dx.doi.org/10.1111/jam.13506] [PMID: 28598022]
[129]
Chang, C-J.; Dai, R-Y.; Leu, Y-L.; Tsai, T-Y. Effects of the melanogenic inhibitor, uracil, derived from Lactobacillus plantarum TWK10-fermented soy milk on anti-melanogenesis in B16F0 mouse melanoma cells. J. Funct. Foods, 2015, 17, 314-327.
[http://dx.doi.org/10.1016/j.jff.2015.05.022]
[130]
Chang, C-J.; Tsai, T-Y. Antimelanogenic effects of the novel melanogenic inhibitors daidzein and equol, derived from soymilk fermented with Lactobacillus plantarum strain TWK10, in B16F0 mouse melanoma cells. J. Funct. Foods, 2016, 22, 211-223.
[http://dx.doi.org/10.1016/j.jff.2016.01.031]
[131]
Bajpai, V.K.; Rather, I.A.; Park, Y-H. Partially purified exo-polysaccharide from Lactobacillus sakei probio 65 with antioxidant, α-glucosidase and tyrosinase inhibitory potential. J. Food Biochem., 2016, 40(3), 264-274.
[http://dx.doi.org/10.1111/jfbc.12230]
[132]
Kwon, S-H.; Hong, S-I.; Kim, J-A.; Jung, Y-H.; Kim, S-Y.; Kim, H-C.; Lee, S-Y.; Jang, C-G. The neuroprotective effects of Lonicera japonica THUNB. against hydrogen peroxide-induced apoptosis via phosphorylation of MAPKs and PI3K/Akt in SH-SY5Y cells. Food Chem. Toxicol., 2011, 49(4), 1011-1019.
[http://dx.doi.org/10.1016/j.fct.2011.01.008] [PMID: 21237235]
[133]
Kim, Y.J.; Uyama, H. Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell. Mol. Life Sci., 2005, 62(15), 1707-1723.
[http://dx.doi.org/10.1007/s00018-005-5054-y] [PMID: 15968468]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 7
Year: 2020
Page: [566 - 577]
Pages: 12
DOI: 10.2174/1389201021666200109104701
Price: $65

Article Metrics

PDF: 26
HTML: 1



Related Article(s)

Most Downloaded Article(s)